You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Correction: Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

Article Text

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

https://doi.org/10.1136/bmjdrc-2019-000705corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Hunt B, Malkin SJP, Moes RGJ, et al. Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands. BMJ Open Diabetes Research and Care 2019;7:e000705. doi: 10.1136/bmjdrc-2019-000705.

    This article was previously published with an error.

    Details of author Bruce Wolffenbuttel have changed. The correct name is Bruce H R Wolffenbuttel and the correct affiliation is University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

    Linked Articles